glp-1 and ocd GLP-1s were designed for diabetes weight loss, but researchers are now exploring whether they may also affect the brain., Early studies suggest medications could influence reward pathways, GLP-1 actions and target organs.
Description
In December 2024, 1.9 million prescriptions of GLP-1s to treat obesity (as opposed to diabetes, for example) were filled, nearly quadruple the number YoY, per IQVIA
Note your fluid intake, bowel habits, urinary symptoms, and semaglutide side effects daily
- 50% as rapid-acting insulin before meals
Figure 6)
